Summary: For more than 25 years, it has been widely appreciated that Ca 2+ influx is essential to trigger T-lymphocyte activation. Patch clamp analysis, molecular identification, and functional studies using blockers and genetic manipulation have shown that a unique contingent of ion channels orchestrates the initiation, intensity, and duration of the Ca 2+ signal. Five distinct types of ion channels -Kv1. and K + channels and hence the functional network can adapt depending upon the state of differentiation and activation, and this allows for different stages of an immune response to be targeted specifically.
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Summary: For more than 25 years, it has been widely appreciated that Ca 2+ influx is essential to trigger T-lymphocyte activation. Patch clamp analysis, molecular identification, and functional studies using blockers and genetic manipulation have shown that a unique contingent of ion channels orchestrates the initiation, intensity, and duration of the Ca (CRAC) channel], TRPM7, and Cl swell -comprise a network that performs functions vital for ongoing cellular homeostasis and for T-cell activation, offering potential targets for immunomodulation. Most recently, the roles of STIM1 and Orai1 have been revealed in triggering and forming the CRAC channel following T-cell receptor engagement. Kv1.3, KCa3.1, STIM1, and Orai1 have been found to cluster at the immunological synapse following contact with an antigen-presenting cell; we discuss how channels at the synapse might function to modulate local signaling. Immuno-imaging approaches are beginning to shed light on ion channel function in vivo. Importantly, the expression pattern of Ca
Introduction
Single cell assays, including electrophysiology and a variety of in vitro and in vivo imaging techniques, have offered unique insights into molecular and cellular mechanisms that underlie cellular activation. In particular, ion channels entered the immunological realm some 25 years ago when it became possible to record electrical signals from single cells of the immune system. In T cells, we have characterized five types of ionic currents, representing electrically the activity of distinct ion channels. Four of these have now been securely identified at the molecular level -most recently through the identification of stromal interacting molecule (STIM) and Orai proteins. Following T-cell receptor (TCR) engagement and endoplasmic reticulum (ER) Ca 2+ store depletion, Ca 2+ unbinds from STIM1's low-affinity luminal EF hand domain. This triggers STIM1 first to oligomerize and then to translocate (empty- Finally, at the level of potential therapeutic benefit, efficacy in animal models points toward a selective immunosuppressive strategy to target Kv1.3 channels for chronic inflammatory and autoimmune disorders, while KCa3.1 and CRAC channel blockers may effectively target acute activation events. In this review, we provide an overview of how lymphocyte ion channels work at the molecular and biophysical levels, how they interact functionally to regulate Ca 2+ signaling, motility, and cell volume, and how the lymphocyte channel phenotype changes during activation and differentiation. We summarize results of Kv1.3 blockers in preclinical studies on animal models. In addition, we provide speculation on the functional consequences of ion channel localization at the immunological synapse and discuss how immuno-imaging approaches are beginning to reveal channel function in vivo.
Biophysical fingerprint and molecular identity of ion channels in T lymphocytes
The development of patch-clamp recording methods by Neher, Sakmann and colleagues (1) provided the means to investigate ion channels in lymphocytes, well before their molecular identities were revealed. Whole-cell recording in human T cells led to the definition of a unique biophysical fingerprint for each of five types of current, all having distinct channel activation requirements. Single-channel recording contributed to this fingerprint and also enabled the number of channels per cell to be determined with single-molecule precision. Ultimately, by comparing the biophysical properties with candidate genes expressed in heterologous systems, the molecular identities of K + and Ca 2+ channels -two of eachwere revealed. Fig. 1 illustrates the five major types of ion channels that have been extensively studied in T lymphocytes.
Kv1.3 and voltage-gated K + current, K V
We (2, 3) and others (4, 5) initially described a voltage-gated K + current in human and murine T cells. The K + current activates when the membrane potential is depolarized (more positive inside the cell), and as a result, K + ions move outward, passively leaving the cell down the K + electrochemical gradient. The process of channel opening is referred to as activation gating. A second gating property called inactivation closes the channel slowly if the membrane potential remains depolarized. Unlike the classical 'ball and chain' mechanism of inactivation described for many other K + channels, the lymphocyte channel inactivates by a conformational change at the external side of the channel pore (6-8), resulting in use-dependent or cumulative inactivation during repeated episodes of depolarization. These channel-gating characteristics, along with single channel properties and a distinctive pharmacological profile described below, provided a unique biophysical fingerprint that enabled the lymphocyte K + channel to be identified as Kv1.3 (HUGO name KCNA3, formerly named MK3, RGK5, or HLK3) (9-11), one of approximately 80 distinct K + channel genes in the human genome. The Kv1.3 channel, like about half of all K + channels, is intrinsically voltage dependent; its conformation changes when the cell is depolarized, leading to an open channel that is specific to K + ions. The pore for specific conduction of K + ions is right in the middle of subunits pre-assembled as a tetramer. A single resting T cell obtained from human peripheral blood typically has approximately 400 functional Kv1.3 channels in the plasma membrane (2) . In T cells under basal conditions, the resting potential is maintained at about )50 mV by only a small fraction of the available Kv1.3 channels (2, 12, 13) . In essence, Kv1.3 by its sigmoid voltage dependence provides protection against depolarization of the membrane potential, thereby ensuring that the lymphocyte's membrane potential does not become significantly depolarized, even if Ca 2+ is entering the cell ( Fig. 2A ).
Kv1.3 is found in the plasma membrane of T cells as part of a signaling complex that includes b1-integrin, a PDZ-domain protein called hDlg (or SAP97), an auxiliary channel subunit Kvb2, an adapter protein ZIP (a.k.a. sequestosome 1 ⁄ p62), and p56 lck (Lck) (14, 15) . It is also present in the inner membrane of mitochondria, where it has been reported to be the target for the apoptotic BAX protein, which binds and occludes the channel pore, thereby altering the membrane potential of the mitochondrion (16, 17) .
Relative to other ion channels, Kv1.3 has an unusually broad sensitivity to pharmacological agents, including some that are usually thought of as hitting different molecular targets. As reviewed previously (14) , Kv1.3 is blocked by small organic compounds in the millimolar to nanomolar range as well as peptide toxins in the nanomolar to picomolar range of potency. The portfolio of Kv1.3 blockers includes (in the approximate order of discovery) canonical but low potency agents previously known to block 'delayed rectifier' K + channels in nerve (2, 3, 18) , ionic blockers (19) , Ca 2+ antagonists, and calmodulin (CaM) antagonists (18, 19) , scorpion peptides (20) (21) (22) (23) (24) (25) , sea anemone peptides (26) (27) (28) , compounds discovered as a result of high-throughput screening efforts (8, 29-31), progesterone (32) , and non-peptidyl compounds resulting from a screen of compounds isolated from the shrub plant Ruta graveolens and the carrot family plant Ammi visnaga (33, 34) . For the scorpion and sea anemone peptide toxins, alanine scanning and complementary mutagenesis have revealed the binding interactions with Kv1.3 (28, (35) (36) (37) (38) (39) . These toxins block from the outside, like a cork in a bottle. A critical positively charged lysine residue on the toxin partially enters the pore between subunits of the tetrameric channel, occupying a site where K + ions normally bind.
Several scorpion and sea anemone peptide toxin variants with improved selectivity for Kv1.3 have been engineered (20, 40, 41) , including a fluorescent toxin analog that can be used in flow cytometry (42) . The most potent of these peptides, (78, 83, 84) (Fig. 3B) . Finally, clinching the identification of Orai (Orai1) as the pore-forming subunit of the CRAC channel, three groups independently showed that mutation of a conserved glutamate residue to aspartate produced a dramatic alteration in ion selectivity such that the CRAC channel activated normally but conducted monovalent cations instead of being selective for Ca 2+ (85) (86) (87) (Fig. 3C,D ).
Orai2 and Orai3 are also capable of forming a CRAC-like current when expressed together with STIM1 in heterologous cells (84, 88, 89 in human T-cell lines (68, 76, 90) and in human T cells (91) , and from nearly complete inhibition of thapsigargin-or TCRinduced Ca 2+ entry by dominant-negative constructs of Orai1 in human T cells (90, 91) . Analysis of knockout mice is presented elsewhere in this volume. The discoveries of Stim and Orai opened the floodgates for recent investigation into the molecular mechanism of CRAC channel activation and the physiological roles of Stim and Orai homologs in various cell types. By co-immunoprecipitation (87), nanometer-scale fluorescence resonance energy transfer (FRET) imaging (92) (93) (94) (95) , and most recently by biochemical analysis of binding by the purified proteins in vitro (96) , the molecular interaction between STIM1 and Orai1 is convincingly shown to be a direct binding interaction. As described above, Ca 2+ sensing and signal initiation are mediated by the N-terminus of Stim within the ER lumen in sequential steps of oligomerization followed by translocation to the plasma membrane (94, 97, 98) . The effector domain of Stim and STIM1 resides within the C-terminal end of the protein situated in the cytosol (94, (99) (100) (101) (102) (103) . Expression of the C-terminus as a cytosolic protein effectively activates CRAC current through the Orai1 (or Orai) channel (94, (99) (100) (101) (102) (103) , as do fragments of the C-terminus as small as 100 amino acids corresponding to the distal coiled-coil domain (96, 104, 105) . Not only does STIM1 translocate to the ER-plasma membrane to activate Orai1 channels, it also organizes them into mirror clusters in the PM (106, 107) , thereby augmenting local Ca 2+ influx. Stim also appears to play a role in determining the stoichiometry of Orai subunits. Orai1 forms relatively stable dimers in cells (90, 101) , but functional data from tandem tetramers of Orai1 strongly suggested that Orai1 is a tetramer when it forms a CRAC channel (108) . Potentially reconciling these studies, when expressed alone, Orai was seen by single-molecule photobleaching as a dimer, but when expressed as a conducting channel activated by the C-terminus of Stim, Orai was shown to be tetrameric (101 (22), leading to the first electrophysiological characterization of an anion and osmolyte efflux that is activated by cell swelling in many cell types (109) . This current has been termed Cl swell or volume-regulated anion current (VRAC). In our first observations, the pipette solution containing ATP was inadvertently hypertonic and caused the cell to swell as we recorded, resulting in the activation of Cl ) current (22) . Moreover, the same current could be activated reversibly by exposure to hypotonic extracellular solution (110, 111) . Cl ) current is induced with a delay of about 1 min following cell swelling, and sustained current is dependent upon cytosolic ATP (111) . Interestingly, hypotonic activation of Cl swell was found to be defective in Lck-deficient T cells, and re-expression of Lck restored osmotic anion current activation (112) . In this study, cell swelling was also shown to activate Lck kinase activity transiently to autophosphorylate. Thus, a phosphorylation event, consistent with the requirement for ATP, may be required to activate the Cl ) channel following cell swelling. In addition to Cl ) ions, the channel also conducts anions such as iodide, bromide, and nitrate, and has a lower permeability to amino acids such as aspartate and glutamate (111) . The molecular identity of swelling-activated Cl ) channels remains enigmatic. Among previously proposed candidate genes, swelling-activated Cl ) conductance is not due to P-glycoprotein, i.e. the multi-drug resistance gene (113), and is very unlikely to be a ClC family member (114) . The most likely candidates at present are homologs of bestrophin (115) or TMEM16A (anoctamin) (116), but both have been associated with a Ca 2+ -activated Cl ) channel with different biophysical properties. Cl swell and Kv1.3 work together functionally in T cells in the regulation of cellular volume (22, 117, 118) . In response to cell swelling, the activation of Cl ) current triggers regulatory volume decrease (RVD) (22, 118) . In mature T cells, RVD is Ca 2+ independent. Cell swelling activates the chloride conductance and, as a result, the membrane potential depolarizes toward the chloride equilibrium potential of )35 mV due to negatively charged Cl ) ions leaving the cell. The resultant depolarization in turn activates Kv1.3 channels. Consequently, the membrane potential remains in between the resting potential and the chloride equilibrium potential, and the cell loses both K + and Cl ) . After several minutes, during which water molecules are also lost, the cell shrinks back to the original volume and the chloride channel shuts. Consistent with Kv1.3 being the main efflux pathway in T cells, the ability to undergo RVD parallels the level of expression of voltage-gated K + conductance, and RVD is inhibited by K + channel blockers (119) . In thymocytes, RVD has a Ca 2+ -dependent component that is independent of CRAC channel activity; it is triggered by a stretch-activated Ca 2+ influx that leads to activation of Ca 2+ -activated K + current (118) . Thus, KCa3.1 channels are recruited to promote RVD in thymocytes. The combined efflux of K + ions through both Kv1.3 and KCa3.1 restores the cell volume more rapidly than either one alone (118) . Physiologically, RVD may come into play homeostatically for ongoing adjustment of T-cell volume and intracellular tonicity and to restore normal volume in response to a diluting environment within the kidney.
TRPM7 and MIC current, role in Mg 2+ homeostasis
Years after K V , K Ca , Cl swell , and CRAC currents were described, yet another current was characterized in T cells, specifically when Mg 2+ ions were omitted from the pipette solution (120) . This current exhibited outward rectification and carried monovalent and divalent cations non-specifically. Now referred to as the Mg
2+
-inhibited Ca 2+ -permeable (MIC) current (121) and also termed MagNuM (for magnesium nucleotide metal) cation current (122) , the current develops with a similar time course to CRAC current during whole-cell recording but exhibits distinct biophysical properties. It has a much larger single-channel conductance, a different mechanism of activation, much less ion selectivity among cations, and different pharmacological sensitivities (121) (122) (123) . MIC current is found in resting and activated T cells, in thymocytes, and in numerous other cell types (124) (125) (126) (127) (128) (129) (130) . The cloning of TRPM7 (originally named LTRPC7 or TRP-PLIK) and studies on heterologous cell types clarified the molecular identity of the outward-rectifying MIC (MagNuM) current, and raised new issues of the channel-gating mechanism (131, 132) . The protein consists of a typical TRP channel domain that presumably forms a tetrameric pore through which both monovalent and divalent cations can pass, followed by a long C-terminal tail that includes a functional a kinase domain. Conducting transmembrane current and having intrinsic kinase activity, this is one of the few channelenzymes that exist. At the molecular level, the mechanism by which cytosolic Mg 2+ inhibits MIC-TRPM7 current has been -activated non-selective cation current due to TRPM4 (158) . To our knowledge, these currents have not been observed in human T cells. Jurkat T cells and monocyte cell lines also reportedly express cyclic ADP ribose-activated channel activity (159) (160) (161) (190, 191) .
Critical to the outcome of the T cell-APC encounter, a T-cell Ca 2+ signal must be of sufficient intensity and duration to result in changes in gene expression. The Ca 2+ dependence and kinetics of NFAT-mediated gene expression were determined at the level of single cells using a gene expression reporter T-cell line (192 to 300 nM to drive gene expression effectively in the majority of cells (192) . Moreover, a hierarchy of signaling pathways was defined in which elevated Ca 2+ was absolutely required:
PKC stimulation alone had no effect, elevation of cAMP was shown to be inhibitory for Ca 2+ -stimulated gene expression, but cAMP inhibition could be overridden by concomitant activation of PKC (192) . The relationship between Ca 2+ dynamics and different gene expression pathways was further examined by Lewis and colleagues (193, 194) , also using thapsigargin to clamp cytosolic Ca 2+ to varying levels and oscillatory frequencies. Rapid oscillations efficiently produced gene expression via NFAT, Oct ⁄ OAP, or NF-jB, whereas infrequent oscillations were effective in driving only NF-jB. Ca 2+ oscillations may serve to drive gene expression efficiently but without the dangerous consequence for cells of prolonged elevation of cytosolic Ca 2+ . As described elsewhere in this volume, gene expression array profiling of control and SCID patient T cells reinforced the central role of Ca 2+ signaling and CRAC channel function in T-cell activation (195) . Channels at the immunological synapse Both Kv1.3 and KCa3.1 in T cells are recruited to the immunological synapse during antigen presentation (15, (196) (197) (198) (199) (200) .
More recently, we showed that STIM1 and Orai1 also re-localize at the DC interface within 5 min of contact, resulting in localized Ca 2+ influx into the synaptic region of the T cell (91) . Channel function and Ca 2+ signaling do not appear important for initial formation of the immunological synapse, as inhibiting either Kv1.3 (15, 197) or CRAC channels (91) did not prevent molecular clustering in the contact zone. However, the long-term stability of the immunological synapse was shown to be compromised by blocking Ca 2+ entry in combination with increasing intracellular Ca 2+ buffering (184, 201) , although the initial contact formation and redistribution of CD3 to the contact area was not affected (201 (202, 203) or the dissolution of STIM1 puncta (204) . It could also serve to stabilize the synapse (201) or perform other functions that require occupancy of a relatively low affinity Ca 2+ binding site.
Mitochondria accumulate in the subsynaptic region of the T cell and help to maintain CRAC current by removing Ca 2+ from the region (205) (206) (207) (208) .
(ii) Ca 2+ entry could also produce significant localized depletion of extracellular Ca 2+ from within the cleft between the T cell and the APC. The volume within this region of contact is unknown but can be estimated by multiplying the combined surface areas of central (c-) and peripheral (p-) supramolecular activation cluster (SMAC) zones, approximated here to be on the order of 10 lm 2 , by the distance between the T cell and the APC. The minimal average width of the synaptic cleft has been estimated using electron microscopy to be 20 nm between a T cell and a DC (209) and on the same order for NK target cell synapses (210), close enough for direct molecular interactions including the engagement of peptide-major histocompatibility complex (MHC) by TCR, as well as integrins (ICAM1-LFA), costimulatory molecules (CD80 ⁄ 86-CD28), and other direct interactions in the synapse. Previous estimates, based on size exclusion of membrane proteins, reached a similar conclusion that the cleft width is between 15 and 40 nm (211, 212). The high density of such proteins interacting in the gap could greatly reduce the effective diffusion coefficient of ions in the synaptic cleft, either by displaying ionic binding sites or by simply occupying a significant amount of space. The actual contact zone is multifocal, with regions of extremely close membrane apposition interspersed in a wider synaptic zone (209) . However, for simplicity we considered the cleft to be a cylinder and estimated the volume within the synaptic cleft as 0. depolarization. Further speculation is perhaps unwarranted without additional experiments, but the mechanism outlined here involving K + accumulation in the T cell-DC synaptic cleft could call CaV voltage sensors into play, possibly even if they lacked functional pores, and it could enable functionally significant communication from the T cell to the APC and back again by delivering a greater quantity of peptide-MHC to the APC surface.
(iv) As Kv1.3 is in physical association with a large signaling complex (Fig. 6) , its localization at the immunological synapse promotes the clustering of associated proteins at the synapse. Colocalization of these proteins into a signalosome at the immunological synapse may provide a mechanism to couple external stimuli with intracellular signaling cascades. ZIP is a multi-functional protein (217, 218) that links the Kv1.3 auxiliary subunit Kvb2 to Lck (15) . ZIP binds ubiquitin noncovalently and could affect signal transduction through ubiquitination-mediated protein degradation (219) . ZIP also binds to other proteins and may thereby regulate T-cell activation: to ras GTPase-activating protein, a negative regulator of the ras signaling pathway (217, 218) , to p38-MAPK and PPARa (220) , to TNF receptor-associated factor 6 (221), a regulator of NF-jB activation, and protein kinase Cn (222) . Protein kinase Cn promotes T-cell polarity and uropod formation during locomotion and dendritic cell scanning (223) . The Kv1.3-Kvb2-ZIP-Lck complex may be targeted under hypoxic conditions leading to reduced T-cell activation. Hypoxia suppresses Kv1.3 through an Lck-mediated mechanism resulting in membrane depolarization and attenuated calcium signaling (224, 225) . Hypoxia also enhances the clearance of ZIP proteins (226) . Kvb2 shows structural homology with aldo-keto reductases (227) , catalyzes the reduction of a variety of aldehydes and ketones (228) , and binds pyridine nucleotides (NADP) with high affinity; moreover, the integrity of the NADP + binding pocket is essential for trafficking of Kv1.x channels to the cell surface (229) . The C-terminus of Kv1.3 is linked to Lck via a PDZ-domain protein called hDlg (also referred to as SAP97) (230) . hDlg binds to GAKIN, a member of the family kinesin motor proteins, and the hDlg-GAKIN complex may contribute to the reorganization of the cortical cytoskeleton during activation (231) . Kv1.3 may also function as a physical bridge between b1-integrin (232) and the signaling molecules described above, thereby functionally coupling external integrin interactions to signal transduction internally. Such coupling could be enhanced by local accumulation of extracellular K + in the synaptic cleft, as elevated extracellular K + has been reported to activate T-cell b1-integrin and to induce integrin-mediated adhesion (232) . Finally, the close proximity of Kv1.3 to its partners within the signaling complex affords a mechanism for channel regulation. Triggering through the Fas ⁄ apoptotic receptor leads via Lck to tyrosine phosphorylation of Kv1.3, resulting in channel suppression (233, 234) . In other tissues (e.g. olfactory bulb) phosphorylation of Kv1.3 at Y449 (in the C-terminus) and ⁄ or YYY 11-113 in the N-terminus contributes to channel suppression (235, 236) . In summary, Kv1.3 may serve as a scaffold that couples the T-cell antigen receptor complex to b1 integrin and to intracellular signaling molecules that modulate the activation process. The KCa3.1 ⁄ CaM channel complex is physically coupled to nucleoside diphosphate kinase B (NDPK-B) (also referred to as nm23-H2) and histidine phosphatase (PHPT-1) (55, 56) . Both proteins modulate KCa3.1 function by phosphorylating ⁄ dephosphorylating His 358 in the C-terminus of the channel, and both may cluster at the immunological synapse together with KCa3.1. At the immunological synapse, NDPK-B may link KCa3.1 and b1-integrin through its interaction with integrin cytoplasmic domain-associated protein 1alpha (ICAP-1a), a protein that binds to the intracellular portion of b1-integrin (237) (Fig. 6) .
Role of K + channels in lymphocyte activation
In the 1980s, several groups showed that chemically diverse blockers of the Kv1.3 channel inhibit mitogen-induced T-cell proliferation, protein synthesis, IL-2 production, allogeneic mixed lymphocyte response (MLR), autologous MLR but not expression of IL-2 receptors (3, 18, (238) (239) (240) . A parallel potency sequence was observed for K V channel blockade and T-cell suppression: TEA < 4AP < diltiazem < quinine < verapamil. Of interest was the discovery that classical 'Ca 2+ channel antagonists' (dilitiazem and verapamil) inhibit T-cell activation by blocking K V channels (18, 19) . In the late 1980s, charybdotoxin, a 37-residue peptide from scorpion venom, was discovered to block Kv1.3 (22, 24) and also to suppress IL-2 production and proliferation of human T cells (239) . Kv1.3 peptide inhibitors from scorpion venom (noxiustoxin and margatoxin), and from sea anemones (ShK), were shown to suppress T-cell activation and Ca 2+ signaling in human T cells (59, 166, 241, 242) . Collectively, these studies established an essential role for the Kv1.3 channel in T-cell proliferation.
What is the mechanism of suppression? A 24-h delay in the addition of the Kv1.3 blockers reduces the effectiveness of T-cell suppression (18) , suggesting that inhibition of an early event during T-cell activation is required for the immunosuppressive effect of the blockers. As exogenous recombinant IL-2 reverses inhibition by Kv1.3 blockers (18, 239) , attention was focused on the signaling events that led to IL-2 production. Studies with peptide toxin inhibitors of Kv1.3 revealed that the anti-proliferative effect of the blockers was due to membrane depolarization and consequent reduced calcium entry (165, 166, 242, 243) . Subsequent studies with other more selective Kv1.3 blockers or genetic silencing of Kv1.3 confirmed the role of membrane depolarization and attenuated calcium signaling in mediating the immunosuppressive effect of Kv1.3 blockers (15, 59, 241, 244, 245) .
Changes in the ion channel phenotype in lymphocyte subsets
The expression pattern of ion channels in a particular T cell defines its channel phenotype. Expression levels can vary dramatically in different cell types, subsets, states of activation, and states of secondary differentiation. Further adding to the complexity, human and murine immune responses and lymphocytes differ in their functional characteristics (246) . Even rat and mouse have significant differences in channel phenotypes (247) . With several channels to distinguish, it is not surprising that we have an incomplete data set. Yet, some functionally important generalizations regarding the phenotype of the two main lymphocyte K + channels have emerged.
Moreover, recent studies have shown that CRAC channels (STIM1 and Orai1,2,3) may also exhibit increased expression Kv1.3 and KCa3.1 expression levels vary during T-cell activation and differentiation into memory T cells (Fig. 7) . Under basal conditions, quiescent naive (CD4 + or CD8 + CCR7 + CD45RA + ) human T cells express predominantly voltage-gated Kv1.3 channels at levels corresponding to a few hundred functional channels per cell (2, 3, 248) . By contrast, quiescent mouse and rat T cells have much lower levels of voltage-gated K + channel activity at fewer than 10 channels per cell (40, 249) . Within a day of activation, the expression of Kv1.3 increases in mouse and rat naive T cells to levels seen in human T cells (approximately 300-500 Kv1.3 channels per cell) (40, (248) (249) (250) . Consistent with a moderate to high level of expression when cells are proliferating, Kv1.3 is also expressed at a higher level in rapidly proliferating mouse thymocyte subsets than in mature single positive mouse subsets (147, 251). Expression of Ca 2+ -activated KCa3.1 channels increases dramatically upon activation of human, mouse, and rat naïve T cells from fewer than 10 channels per cell in quiescent cells to an average of approximately 500 channels per cell (40, 50, 59 ) and effector memory T EM (CCR7 ) CD45RA ) ) T cells were visualized by fluorescence microscopy and single-cell patch clamp studies were performed on T cells belonging to specific subsets. In other experiments, CD4 + or CD8 + T cells from human peripheral blood were stimulated for 48 h with anti-CD3 or PMA + ionomycin, immunostained, and activated cells (enlarged) corresponding to each of the subsets described above were patch clamped. The Kv1.3 and KCa3.1 channels were identified by their unique biophysical and pharmacological fingerprint. The numbers of functional channels ⁄ cell were determined by dividing the total Kv1. 3 tion of these cells. By contrast, ShK suppressed the activation of class-switched memory B cells stimulated by anti-CD40 antibody or the PMA ⁄ ionomycin combination, and TRAM-34 was not effective (256) . Thus, KCa3.1 channels are the primary regulators of membrane potential and calcium signaling in effector cells derived from naïve or early memory B or T cells, and Kv1.3 plays this role in effectors generated from late memory B or T cells.
The functional involvement of ion channels extends also to NK cells that also express Kv1.3 channels. NK cells actively patrol lymph nodes and are capable of engaging and destroying foreign cells in swarms that contact and kill the targets (260) . During target recognition, CRAC channels are probably activated, producing an oscillatory Ca 2+ signal (165) that results in secretion of cytolytic granules and elimination of foreign cells. The secretion of cytolytic granules by NK cells and killing of target cells relies on Kv1.3 to sustain the membrane potential (261, 262) .
Increases in functional CRAC and K + channel expression: a positive feedback loop during T-cell activation
In addition to changes in K + channel expression that take place during activation of naive T cells, the CRAC channel components STIM1 and Orai1 and also Orai2 and Orai3 are upregulated at the mRNA level in T-cell blasts within a day of TCR engagement, a change in channel phenotype that lasts for at least 6 days (91) . These changes take place in parallel to upregulation of functional KCa3.1 channels and Kv1.3 channels (50, 263) . Thus, all three channel types that are involved directly or indirectly in Ca 2+ signaling in T cells are upregulated upon mitogenic activation following TCR engagement. In RBL cells, functional CRAC channels are expressed at the highest level during G1S and S phases of the cell cycle and are strongly downmodulated during mitosis (127 Visualizing lymphocyte activation and drug action and envisioning the role of ion channels in vivo
Introduced to the field of immunology in 2002, two-photon microscopy permits real-time visualization of living cells within their native environment in vivo (191, 264, 265) . The basal motility pattern of both T and B cells is a stop-and-go three-dimensional random walk. The robust motility of T cells in lymph nodes suggested an antigen-search strategy carried out independently by lymphocytes acting autonomously (266) . When specific antigen peptide-MHC is detected, a cascade of events is triggered in T cells that leads to Ca 2+ signaling and lymphocyte activation; the T-cell response evolves in three distinct phases for both CD8 + cells and CD4 + cells (267, 268) .
In phase I, T cells make serial, transient contacts with several antigen-bearing DCs. During the initial phase, T cells respond with a Ca 2+ signal (186, 187) , that later results in enhanced gene expression, cytokine secretion, and cell proliferation. In phase II, T cell-DC contact durations increase, leading to prolonged interactions as several T cells cluster around individual DCs. During phase III, enlarged T-cell blasts resume their motility and swarm about DCs, again making serial contacts before undergoing cell division. Meanwhile, after engaging soluble antigen, B cells migrate in a directed manner toward the follicle edge (269) , where they appear to capture helper T cells and migrate together as conjugate pairs with the B cell leading the way. The elegant cellular choreography within lymph nodes provides an efficient means for T cells to locate rare antigens in the tissue environment, to activate only when appropriate, and to migrate to the peripheral source of antigen where chemokine secretion coordinates inflammation. In addition, it provides the means for B cells dispersed in the follicle to collect antigen and migrate toward the T cells to obtain help. Just as there is a complex cellular choreography based upon cell-to-cell contacts and recognition, so too there is choreography at the molecular level in T cells (270) (271) (272) . We may envision the activity of ion channels as the three phases of T cell-DC interactions evolve. During phase I, the intermittent contacts between T cells and DCs are accompanied by short bursts of Ca 2+ signaling through CRAC channels. At this time, Two-photon microscopy is opening a new window for imaging cell motility, interaction dynamics, and drug action in vivo. We imaged the cellular responses to two classes of candidate immunosuppressive drugs. In the presence of an S1P 1 receptor agonist that mimics the action of FTY-720 in producing sequestration of lymphocytes within the lymph node, resulting in lymphopenia and a paucity of T EM cells in the periphery (273) , two-photon imaging within the lymph node revealed lymphocytes logjammed adjacent to lymphatic endothelial cells that line the medullary sinus. Upon removal of the agonist or addition of a competitive antagonist, lymphocytes were imaged traversing into the medullary sinus to egress from the node (274, 275) . These studies documented the feasibility of in vivo imaging to investigate drug action and highlighted the importance of S1P 1 receptor agonism, not antagonism, as being essential for blocking lymphocyte egress to suppress the immune response in peripheral tissues.
In a more recent study, we imaged the behavior of T EM cells during a delayed-type hypersensitivity (DTH) response, as a model for inflammation caused by skin-homing T EM cells (276 More than 80 different autoimmune diseases are known, and together these affect nearly 120 million people globally. A therapy that functionally inhibits or eliminates disease-specific autoantigen-specific immune responses without compromising the protective immune response is the Holy Grail in the quest to treat autoimmune disease. One approach to achieving this goal is to selectively target T EM cells that have been implicated in the pathogenesis of many autoimmune diseases. Specific inhibitors of Kv1.3 offer an exciting new approach to mute autoreactive T EM cell responses in diverse autoimmune without compromising the protective immune response.
In human patients, K + channel phenotyping has particular relevance to autoimmune disorders. In T-cell clones from patients with multiple sclerosis (MS) and type 1 diabetes, Kv1.3 expression was found to be high only in clones of the appropriate antigen specificity (248) . For example, in new onset type 1 diabetics, GAD-or insulin-specific patient T cells were CCR7 ) T EM effectors that expressed >1000 Kv1.3 channels, whereas myelin-specific T patient cells were CCR7 + T cells exhibiting the Kv1.3 expression pattern of quiescent cells (15) . In patients with MS, the converse expression pattern was found (15, 278) . In a patient with both MS and type 1 diabetes, Kv1.3 expression was high in both MBP-and GADspecific T cells (15) . MHC-tetramer-sorted GAD65-specific CD4 + T cells from type 1 diabetic subjects were also CCR7 (283, 284) , and they prevent the spontaneous development of autoimmune diabetes in BB rats (15) . In minipigs, the Kv1.3 channel blockers, margatoxin and correolide, suppress DTH to tuberculin, and, 2-3 weeks following the cessation of treatment, DTH could not be elicited by repeat challenge with tuberculin (285, 286) . This period of 'remission' by Kv1.3 blocker therapy may be the result of the death-by-neglect mechanism whereby tuberculin-specific skin-homing T EM cells are immobilized and then deleted at the site of DTH. Kv1.3 blockers also suppress the primary but not the secondary antibody response to allogeneic antibody in minipigs (285, 286) . Clofazimine, the recently discovered Kv1.3 blocker, prevents rejection of human skin grafts in immunodeficient Pfb-Rag2 ) ⁄ ) mice (which lack T, B, and NK cells) following the adoptive transfer of allogeneic human T cells (244) . In summary, Kv1.3 blockers have proven efficacy in seven rat models of autoimmune disease (two models of EAE, DTH, contact dermatitis, rheumatoid arthritis, type 1 diabetes, and bone resorption secondary to periodontitis), in a minipig model for DTH and allogeneic antibody responses, and in a SCID-hu mouse model for allogeneic skin graft rejection. Inhibition of Kv1.3 offers a good approach to modulate pathologic immune responses mediated by autoreactive T EM cells in animal models, but an important issue in developing Kv1.3 blockers as therapeutics is the balance between efficacy and safety. Clofazimine has been used in humans for nearly 70 years. It is generally safe, although it causes reversible skin discoloration in many patients. Prolonged therapy with high concentrations of clofazimine results in the formation of drug crystals in tissues, leading to bullseye retinopathy, vortex keratopathy, enteropathy, splenic infarction, and, in one case, death (287) (288) (289) (290) . In minipigs, margatoxin and correolide did not cause overt toxicity, although continuous infusion of margatoxin induced mild hypersalivation and decreased appetite, while a higher dose administered as an intravenous bolus resulted in transient hyperactive behavior (286) . The selective Kv1.3 blockers (ShK-186, ShK-170, and PAP-1) have been found to be safe in rats and monkeys. They exhibit greater than 10 000-fold selectivity over the HERG channel that underlies many drug-induced cardiac arrhythymias, and ShK-170 did not alter heart rate variability parameters in rats (279) . ShK-170 and PAP-1 were not cytotoxic on a panel of mammalian cells and were negative in the Ames test (49, 279) . ShK-170 and ShK-186 administered daily for 2-4 weeks did not cause clinical toxicity and did not change blood counts, blood chemistry, or histopathology of a panel of tissues (15, 279) . PAP-1 showed an excellent safety profile in rats administered the drug daily for 6 months and in monkeys (Macaca mulata) given the drug daily for a month (291) . Importantly, selective Kv1.3 blockers did not compromise the protective immune response to acute viral (influenza) or bacterial (chlamydia) infections at pharmacological doses that ameliorate autoimmune diseases (276) . After repeated subcutaneous administration for 28 days, ShK-186 elicited low titer antiShK antibodies (15) , but these antibodies do not appear to be neutralizing in DTH. The relative safety of Kv1.3 blockers may be due in part to channel redundancy and partly because Kv1.3 blockers may not inhibit Kv1.3-containing heteromultimers (e.g. in the central nervous system) with the same affinity as Kv1.3 homotetramers in T cells. Together, these data suggest that selective Kv1.3 blockers may be excellent candidates for continued development for treatment of autoimmune diseases.
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